The effectiveness of treatment for pediatric obsessive-compulsive disorder: A meta-analysis

Behavior Therapy

Volumn 36, Issue 1, 2005, Pages 55-63

  Abramowitz, Jonathan S ^a   Whiteside, Stephen P ^a   Deacon, Brett J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

BEHAVIOR THERAPY; CHILD PSYCHIATRY; CLINICAL TRIAL; COGNITIVE THERAPY; HUMAN; META ANALYSIS; OBSESSIVE COMPULSIVE DISORDER; PSYCHODYNAMICS; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 24944475781     PISSN: 00057894     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-7894(05)80054-1     Document Type: Article

References (41)

1. Abramowitz, J. S. (1997). Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative review. Journal of Consulting and Clinical Psychology, 65, 44-52.
2. Ackerman, D., & Greenland, S. (2002). Multivariate meta-analysis of controlled drug trials for obsessive-compulsive disorder. Journal of Clinical Psychopharmacology, 22, 309-317.
3. Benazon, N. R., Ager, J., & Rosenberg, D. R. (2002). Cognitive-behavior therapy in treatment-naïve children and adolescents with obsessive-compulsive disorder: An open trial. Behaviour Research and Therapy, 40, 529-539.
4. Bolton, D., Collins, S., & Steinberg, D. (1983). The treatment of obsessive-compulsive disorder in adolescence: A report of fifteen cases. British Journal of Psychiatry, 142, 456-464.
5. de Haan, E., Hoogduin, K., Buitelaar, J., & Keijsers, G. P. J. (1998). Behavior therapy versus clomipramine for treatment of obsessive-compulsive disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 1022-1029.
6. DeVeaugh-Geiss, J., Moroz, G., Biederman, J., Cantwell, D., Fontaine, R., Greist, J. H., Reichler, R., Katz, R., & Landau, P. (1992). Clomipramine hydrochloride in childhood obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 45-49.
7. Flament, M. F., Rapoport, J. L., Berg, C. J., Sceery, W., Kilts, C., Mellstrom, B., & Linnoila, M. (1985). Clomipramine treatment of childhood obsessive-compulsive disorder: A double-blind controlled study. Archives of General Psychiatry, 42, 977-983.
8. Flament, M. F., Rapoport, J. L., Whitaker, A., Davies, M., Kalikow, K., & Shaffer, D. (1988). Obsessive-compulsive disorder in adolescence: An epidemiological study. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 764-771.
9. Franklin, M., Kozak, M., Cashman, L., Coles, M., Rheingold, A., & Foa, E. (1998). Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: An open clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 412-419.
10. Gibbs, N. (1996). Nonclinical populations in research on obsessive-compulsive disorder: A critical review. Clinical Psychology Review, 16, 729-773.
11. Grados, M., Scahill, L., & Riddle, M. (1999). Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. Child and Adolescent Psychiatric Clinics of North America, 8, 617-634.
12. Greist, J. H., Jefferson, J. W., Kobak, K. A., Katzelnick, D. J., & Serlin, R. C. (1995). Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: A meta-analysis. Archives of General Psychiatry, 52, 53-60.
13. Hedges, L. (1982). Estimation of effect size from a series of independent experiments. Psychological Bulletin, 92, 490-499.
14. Hedges, L., & Olkin, I. (1985). Statistical methods for meta-analysis. New York: Academic Press.
15. Jacobson, N., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12-19.
16. Karno, M., & Golding, J. M. (1991). Obsessive compulsive disorder. In L. N. Tovins & D. A. Refier (Eds.), Pediatric disorders in America (pp. 204-219). New York: Free Press.
17. Leonard, H., Swedo, S., Lenane, M., Rettew, D., Cheslow, D., Hamburger, D., & Rapoport, J. (1991). A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Archives of General Psychiatry, 48, 922-927.
18. Leonard, H., Swedo, S., Rapoport, J., Koby, E., Lenane, M., Cheslow, D., & Hamburger, S. (1989). Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents: A double-blind comparison. Archives of General Psychiatry, 46, 1088-1092.
19. Liebowitz, M., Turner, S., Piacentini, J., Beidel, D., Clarvit, S., Davies, S., Graae, E, Jaffer, M., Lin, S., Sallee, F., Schmidt, A., & Simpson, H. B. (2002). Fluoxetine in children and adolescents with obsessive-compulsive disorder: A placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1431-1438.
20. March, J. S., Biederman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E., Cutler, N. R., Dominguez, R., Ferguson, J., Muller, B., Riesenberg, R., Rosenthal, M., Sallee, F. R., & Wagner, K. D. (1998). Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial. Journal of the American Medical Association, 280, 1752-1756.
21. March, J., Frances, A., Carpenter, D., & Kahn, D. (1997). Expert Consensus Guidelines on obsessive-compulsive disorder. Journal of Clinical Psychiatry, 58(Suppl. 4).
22. March, J., & Leonard, H. (1996). Obsessive-compulsive disorder in children and adolescents: A review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1265-1273.
23. March, J. S., & Mulle, K. (1998). OCD in children and adolescents: A cognitive-behavioral treatment manual. New York: The Guilford Press.
24. March, J., Mulle, K., & Herbel, B. (1994). Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: Open trial of a new protocol-driven treatment package. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 333-341.
25. Morris, S. B., & DeShon, R. P. (2002). Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychological Methods, 7, 105-125.
26. Orwin, R. (1983) A fail safe N for effect size in meta-analysis. Journal of Educational Statistics, 8, 157-159.
27. Pediatric OCD Treatment Study Team. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder. JAMA, 292, 1969-1976.
28. Piacentini, J., Bergman, R. L., Jacobs, C., McCracken, J. T., & Kretchman, J. (2002). Open trial of cognitive behavioral therapy for childhood obsessive-compulsive disorder. Journal of Anxiety Disorders, 16, 207-219.
29. Rapoport, J. L., & Inoff-Germain, G. (2000). Practitioner review: Treatment of obsessive-compulsive disorder in children and adolescents. Journal of Psychology and Psychiatry, 43, 419-431.
30. Rasmussen, S., & Eisen, J. (1990). Epidemiology of obsessive-compulsive disorder. Journal of Clinical Psychiatry, 53(Suppl.), 10-54.
31. Ray, J. E., & Shadish, W. R. (1996). How interchangeable are different measures of effect size? Journal of Consulting and Clinical Psychology, 64, 1316-1325.
32. Riddle, M. A., Reeve, E. A., Yaryura-Tobias, J. A., Yang, H. M., Claghorn, J. L., Gaffney, G., Greist, J. H., Holland, D., McConville, B. J., Pigott, T., & Walkup, J. T. (2001). Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized controlled multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 222-229.
33. Riddle, M. A., Scahill, L., King, R., Hardin, M., Anderson, G. M., Ort, S., Smith, J. C., Leckman, J. F., & Cohen, D. J. (1992). Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1062-1069.
34. Rosenberg, D., Stewart, C. M., Fitzgerald, K. D., Tawile, V., & Carroll, E. (1999). Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1180-1185.
35. Scahill, L. C., Vitulano, L. A., Brenner, E. M., Lynch, K. A., & King, R. A. (1996). Behavioral therapy in children and adolescents with obsessive-compulsive disorder: A pilot study. Journal of Child and Adolescent Psychopharmacology, 6, 191-202.
36. Steketee, G. S., Frost, R. O., & Bogert, K. (1996). The Yale-Brown Obsessive-Compulsive Scale: Interviewer versus self-report. Behaviour Research and Therapy, 34, 675-684.
37. Thienemann, M., Martin, J., Cregger, B., Thompson, H. B., & Dyer-Friedman, J. (2001). Manual-driven group cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: A pilot study. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1254-1260.
38. Thomsen, P. H. (2000). Obsessive-compulsive disorder: Pharmacological treatment. European Child and Adolescent Psychiatry, 9, i76-i84.
39. Trull, T., Nietzel, M., & Main, A. (1988). The use of meta-analysis to assess the clinical significance of behavior therapy for agoraphobia. Behavior Therapy, 19, 527-538.
40. Van Balkom, A, van Oppen, P., Vermeulen, A., van Dyck, R., Nauta, M., & Vorst, H. (1994). A meta-analysis on the treatment of obsessive-compulsive disorder: A comparison of antidepressants, behavior, and cognitive therapy. Clinical Psychology Review, 34, 359-381.
41. Wever, C., & Rey, J. M. (1997). Juvenile obsessive-compulsive disorder. Australian and New Zealand Journal of Psychiatry, 31, 105-113.